Clinical Trials Browser

Not yet recruiting × Multiple Myeloma × Denosumab × Clear all

NCT06314698 2024-03-18

Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease

Phase 3 Not yet recruiting

Bone Diseases, Multiple Myeloma